1 completed, 1 not yet recruiting, 1 recruiting. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 1, Not yet recruiting 1, Recruiting 1 |
Follow abrysvo: new trials by email Literature Review of abrysvo trials Research Report on abrysvo
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Prevention of RSV Infection in Infants by Administering Nirsevimab to Infants, With or Without Maternal RSV Vaccination Nirsevimab, Abrysvo - RSV Immunization | Phase 3 | Recruiting | Centre Hospitalier Annecy Genevois | 1000 | 2026-05-06 | 2026-05-27 |
| Pregnancy and Infant PrEparedness pLatform IN Europe, RSV-International Adaptive Platform Trial to Evaluate Two Approved Prevention Options to Prevent Respiratory Syncytial Virus in Infants: Maternal Vaccine to Women in Pregnancy and Monoclonal Antibody to the Infants, Given Alone or in Combination. Abrysvo, Nirsevimab - RSV Immunization | Phase 3 | Not yet recruiting | PENTA Foundation | 1500 | 2025-09-01 | 2025-06-27 |
| A Study to Evaluate the Safety and Immunogenicity of RSVpreF Coadministered With Herpes Zoster Vaccine in Adults RESPIRATORY SYNCYTIAL VIRUS PREFUSION F SUBUNIT VACCINE, HZ/su VACCINE - Respiratory Syncytial Virus (RSV) | Phase 3 | Completed | Pfizer | 526 | 2025-04-04 | 2025-11-06 |
Respiratory Tract Infections (1)
Centre Hospitalier Annecy Genevois (1) · PENTA Foundation (1) · Pfizer (1)
France (1) · Puerto Rico (1) · United States (1)
Pierre Frange (1)
2025 (2)